GlaxoSmithKline (GSK)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 1295.34p Today's change: +0.38%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 1295.34p 5 day change: +0.61%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 1295.34p 6 month change: -23.41%

Contact details

Address: 980 Great West Road, Brentford, Middlesex, United Kingdom
Phone: +44 (0)20 8047 5000
Fax: +44 (0)20 8047 7807
Website: www.gsk.com

Company information

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

Could a newly-developed inhaled vaccine soon be used to stop the spread of Ebola between humans in west Africa? [...]

4 November 2014
Shares
5

Pharma giant GlaxoSmithKline (GSK) is considering floating its HIV drugs business in a move that would see Viiv [...]

23 October 2014
Shares
28

BRITAIN’S top share index yesterday ended higher, with motor insurers advancing on news of an increase in car [...]

23 October 2014
Shares
2

ViiV Healthcare could generate one of the biggest IPOs in history, if GSK decides to go ahead and make it a spin-off [...]

22 October 2014

GlaxoSmithKline (GSK) has revealed that its Ebola vaccine won't be ready in time to deal with the current epidemic [...]

17 October 2014
Shares
12

GlaxoSmithKline (GSK) has confirmed that Royal Bank of Scotland (RBS) chairman Sir Philip Hampton has been appointed [...]

25 September 2014
Shares
18

SHARES in pharmaceutical giant Glaxo­SmithKline (GSK) rose slightly in late afternoon trading yesterday after [...]

25 September 2014
Shares
2

Shares in pharmaceutical giant GlaxoSmithKline rose slightly in late afternoon trading after it emerged Sir Philip [...]

24 September 2014
Shares
6

The news GSK’s Ebola vaccine is to be trialled on humans failed to lift the company on the stock market this [...]

17 September 2014
Shares
11

Monkeys given an experimental Ebola vaccine developed by GSK were resistant to the deadly virus when infected [...]

8 September 2014
Shares
3

An international consortium is fast-tracking an Ebola vaccine under development by the US National Institutes [...]

28 August 2014
Shares
6

GlaxoSmithKline is facing new bribery allegations in Syria, the latest in a string of accusations flung at the [...]

13 August 2014
Shares
4

Sir Philip Hampton could jump ship to leading pharmaceutical firm GlaxoSmithKline after six years chair­ing RBS, [...]

8 August 2014
Shares
3

Sir Philip Hampton is being lined up to take the role of chairman at Britain’s biggest drug company Glaxosmithkline [...]

7 August 2014
Shares
6

The chief executive of GlaxoSmithKline has said that he is open to the idea of creating a breakaway consumer healthcare [...]

27 July 2014
Shares
25

Content tagged with "GlaxoSmithKline"